Absence of adverse outcomes in hyperkalemic patients undergoing vascular access surgery

Canadian Journal of Anesthesia

Volumn 50, Issue 6, 2003, Pages 553-557

  Olson, Ronald P ^a   Schow, Adam J ^a   McCann, Richard ^a   Lubarsky, David A ^a   Gan, Tong J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM;

ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENERAL ANESTHESIA; HUMAN; HYPERKALEMIA; MEDICAL DOCUMENTATION; NERVE BLOCK; PATIENT CARE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SAFETY; SURGICAL RISK; SYMPTOMATOLOGY; TREATMENT CONTRAINDICATION; VASCULAR ACCESS;

EID: 0041422298     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018639     Document Type: Article

References (29)

1. Mathes DD. Management of acute and chronic renal failure. In: Stone DJ, Bogdonoff D, Leisure GS, Spiekermann BF, Mathes DD. (Eds.). Perioperative Care. St. Louis: Mosby; 1998: 227-31.
2. Roizen MF. Anesthetic implications of concurrent diseases. In: Miller RD (Ed.). Anesthesia, 5th ed. Philadelphia: Churchill Livingstone; 2000: 979-81.
3. Sendak MJ. Monitoring and management of perioperative electrolyte abnormalities, acid-base disorders, and fluid replacement. In: Longnecker DE, Tinker JH, Morgan GE Jr (Eds.). Principles and Practice of Anesthesiology, 2nd ed. St. Louis: Mosby; 1998: 974-9.
4. Paice B, Gray JMB, Mcbride D, Donnelly T, Lawson DH. Hyperkalaemia in patients in hospital. BMJ 1983; 286: 1189-92.
5. Moore ML, Bailey RR. Hyperkalaemia in patients in hospital. N Z Med J 1989; 102: 557-8.
6. Charytan D, Goldfarb, DS. Indications for hospitalization of patients with hyperkalemia. Arch Intern Med 2000; 160: 1605-11.
7. Brenowitz JB, Williams CD, Edwards WS. Major surgery in patients with chronic renal failure. Am J Surg 1977; 134: 765-9.
8. Lissos I, Goldberg B, Van Blerk, PJP, Meijers AM. Surgical procedures on patients in end-stage renal failure. Br J Urol 1973; 45: 359-65.
9. Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients. Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998; 158: 917-24.
10. Pinson CW, Schuman ES, Gross GF, Schuman TA, Hayes JF. Surgery in long-term dialysis patients. Experience with more than 300 cases. Am J Surg 1986; 151: 567-71.
11. National Kidney Foundation K/DOQI clinical practice guidelines for vascular access, 2000. Am J Kidney Dis 2001; 37(Suppl 1): S137-81.
12. Newmark SR, Dluhy RG. Hyperkalemia and hypokalemia. JAMA 1975; 231: 631-3.
13. Levinsky NG. Management of emergencies. VI. Hyperkalemia. N Engl J Med 1966; 274: 1076-7.
14. Wiederkehr MR, Moe OW. Factitious hyperkalemia. Am J Kidney Dis 2000; 36: 1049-53.
15. Halperin ML, Kamel KS. Potassium. Lancet 1998; 352: 135-40.
16. Salem MM, Rosa RM, Battle DC. Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia. Am J Kidney Dis 1991; 18: 421-40.
17. Allon M. Disorders of potassium metabolism. In: Greenburg A (Ed.). Primer on Kidney Diseases, 3rd ed. San Diego: Academic Press; 2001: 98-107.
18. Allon M. Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 1993; 43: 1197-1209.
19. Gifford JD, Rutsky EA, Kirk KA, McDaniel HG. Control of serum potassium during fasting in patients with end-stage renal disease. Kidney Int 1989; 35: 90-4.
20. Clausen T, Everts ME. Regulation of the Na, K-pump in skeletal muscle. Kidney Int 1989; 35: 1-13.
21. Struthers AD, Reid JL, Whitesmith R, Rodger JC. The effects of cardioselective and non-selective β-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci 1983; 65: 143-7.
22. Weintraub HD, Heisterkamp DV, Cooperman LH. Changes in plasma potassium concentration after depolarizing blockers in anaesthetized man. Br J Anaesth 1969; 41: 1048-52.
23. Schow AJ, Lubarsky DA, Olson RP, Gan TJ. Can succinylcholine be used safely in hyperkalemic patients? Anesth Analg 2002; 95: 119-22.
24. Surawicz B, Chlebus H, Mazzoleni A. Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K. Am Heart J 1967; 73: 647-64.
25. Schwartz AB. Potassium-related cardiac arrhythmias and their treatment. Angiology 1978; 19: 194-205.
26. Ettinger PO, Regan TJ, Oldewurtel HA. Hyperkalemia, cardiac conduction, and the electrocardiogram: a review. Am Heart J 1974; 88: 360-71.
27. Tarail R. Relation of abnormalities in concentration of serum potassium to electrocardiographic disturbances. Am J Med 1948; 5: 828-37.
28. Szerlip HM, Weiss J, Singer I. Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis 1986; 7: 461-5.
29. Wrenn KD, Slovis CM, Slovis BS. The ability of physicians to predict hyperkalemia from the ECG. Ann Emerg Med 1991; 20: 1229-32.